Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Hypertension. 2010 Jan 4;55(2):298–304. doi: 10.1161/HYPERTENSIONAHA.109.135426

Table 2.

Response in mean arterial blood pressure (MAP), relative cortical blood flow (CBF) and kidney pO2 to administration of the selective AT2-R blocker PD-123,319 and the combination of PD-123,319 + enalaprilat in a separate group of 2K,1C rats.

Parameter Baseline After PD-123,319 After PD-123,319 + enalaprilat
MAP (mmHg) 162±5 155±5 133±5*
CBF (% of baseline) 100 101±11 88±9
Cortical pO2 (% of baseline) 100 105±3.3 104±5
Medullary pO2 (% of baseline) 100 96±11 91±17

All values are mean ± SEM of n=7.

*

denotes p<0.05 when compared to baseline.

HHS Vulnerability Disclosure